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I am pleased to confirm that Greater Glasgow & Clyde Health Board is now able to grant Approval for the above study. 
 
Conditions of Approval 
1. For Clinical Trials as defined by the Medicines for Human Use Clinical Trial Regulations, 2004 
a. During the life span of the study GGHB requires the following information relating to this site 
i. Notification of any potential serious breaches. 
ii. Notification of any regulatory inspections. 
 
It is your responsibility to ensure that all staff involved in the study at this site have the appropriate GCP training according 
to the GGHB GCP policy (www.nhsggc.org.uk/content/default.asp?page=s1411), evidence of such training to be filed in the 
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